Yahoo
NYSE - Delayed Quote USD

Koninklijke Philips N.V. (PHG)

25.89 -0.16 (-0.61%)
At close: September 4 at 4:00:02 PM EDT
26.26 +0.37 (+1.43%)
After hours: September 4 at 7:50:01 PM EDT
Trade PHG on Coinbase
Chart Range Bar
Loading chart for PHG
  • Previous Close 26.05
  • Open 25.91
  • Bid 25.92 x 30000
  • Ask 27.25 x 40000
  • Day's Range 25.87 - 26.01
  • 52 Week Range 23.85 - 33.44
  • Volume 455,427
  • Avg. Volume 1,046,216
  • Market Cap (intraday) 25.306B
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) 19.61
  • EPS (TTM) 1.32
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield 1.01 (3.89%)
  • Ex-Dividend Date May 13, 2026
  • 1y Target Est 32.21

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

www.philips.com

63,670

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is AEX-Index (^AEX) .

YTD Return

PHG
0.67%
AEX-Index (^AEX)
17.05%

1-Year Return

PHG
3.00%
AEX-Index (^AEX)
23.70%

3-Year Return

PHG
27.88%
AEX-Index (^AEX)
48.98%

5-Year Return

PHG
38.74%
AEX-Index (^AEX)
41.03%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 4.36B
Earnings 384M
Profit Margin 8.81%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
4B
5B
4.0%
5.0%
6.0%
7.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

26.75
32.21 Average
25.89 Current
41.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/3/2026
Analyst UBS
Rating Action Downgrade
Rating Neutral
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.31%

  • Return on Assets (ttm)

    4.07%

  • Return on Equity (ttm)

    10.15%

  • Revenue (ttm)

    17.66B

  • Net Income Avi to Common (ttm)

    1.11B

  • Diluted EPS (ttm)

    1.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.79B

  • Total Debt/Equity (mrq)

    65.05%

  • Levered Free Cash Flow (ttm)

    1.53B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: